BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 34964894)

  • 21. Long-term natural history and patterns of sporadic vestibular schwannoma growth: A multi-institutional volumetric analysis of 952 patients.
    Marinelli JP; Schnurman Z; Killeen DE; Nassiri AM; Hunter JB; Lees KA; Lohse CM; Roland JT; Golfinos JG; Kondziolka D; Link MJ; Carlson ML
    Neuro Oncol; 2022 Aug; 24(8):1298-1306. PubMed ID: 34964894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous Volumetric Tumor Regression During Wait-and-Scan Management of 952 Sporadic Vestibular Schwannomas.
    Marinelli JP; Killeen DE; Schnurman Z; Nassiri AM; Hunter JB; Lees KA; Lohse CM; Roland TJ; Golfinos JG; Kondziolka D; Link MJ; Carlson ML
    Otol Neurotol; 2022 Oct; 43(9):e1034-e1038. PubMed ID: 36001695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stratifying Risk of Future Growth Among Sporadic Vestibular Schwannomas.
    Marinelli JP; Schnurman Z; Killeen DE; Nassiri AM; Hunter JB; Lees KA; Lohse CM; Roland JT; Golfinos JG; Kondziolka D; Link MJ; Carlson ML
    Otol Neurotol; 2023 Aug; 44(7):e519-e524. PubMed ID: 37367632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining clinically significant tumor size in vestibular schwannoma to inform timing of microsurgery during wait-and-scan management: moving beyond minimum detectable growth.
    Macielak RJ; Wallerius KP; Lawlor SK; Lohse CM; Marinelli JP; Neff BA; Van Gompel JJ; Driscoll CLW; Link MJ; Carlson ML
    J Neurosurg; 2022 May; 136(5):1289-1297. PubMed ID: 34653971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lifetime Cost and Quality-Adjusted Life-Years Across Management Options for Small- and Medium-Sized Sporadic Vestibular Schwannoma.
    Macielak RJ; Thao V; Borah BJ; Moriarty JP; Marinelli JP; Van Gompel JJ; Carlson ML
    Otol Neurotol; 2021 Oct; 42(9):e1369-e1375. PubMed ID: 34282100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural History of Growing Sporadic Vestibular Schwannomas During Observation: An International Multi-Institutional Study.
    Marinelli JP; Carlson ML; Hunter JB; Nassiri AM; Haynes DS; Link MJ; Lohse CM; Reznitsky M; Stangerup SE; Caye-Thomasen P
    Otol Neurotol; 2021 Sep; 42(8):e1118-e1124. PubMed ID: 34121081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vestibular Schwannomas.
    Carlson ML; Link MJ
    N Engl J Med; 2021 Apr; 384(14):1335-1348. PubMed ID: 33826821
    [No Abstract]   [Full Text] [Related]  

  • 28. Vestibular Schwannoma Measurements-Is Volumetric Analysis Clinically Necessary?
    Selleck AM; Rodriguez JD; Brown KD
    Otol Neurotol; 2021 Jul; 42(6):906-911. PubMed ID: 33577243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vestibular Schwannoma Practice Patterns: An International Cross-specialty Survey.
    Macielak RJ; Driscoll CLW; Link MJ; Haynes DS; Lohse CM; Carlson ML
    Otol Neurotol; 2020 Dec; 41(10):e1304-e1313. PubMed ID: 33492806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The natural history of vestibular schwannoma growth-prospective 40-year data from an unselected national cohort.
    Reznitsky M; Petersen MMBS; West N; Stangerup SE; Cayé-Thomasen P
    Neuro Oncol; 2021 May; 23(5):827-836. PubMed ID: 33068429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural History of Growing Sporadic Vestibular Schwannomas: An Argument for Continued Observation Despite Documented Growth in Select Cases.
    Marinelli JP; Lees KA; Lohse CM; Driscoll CLW; Neff BA; Link MJ; Van Gompel JJ; Carlson ML
    Otol Neurotol; 2020 Oct; 41(9):e1149-e1153. PubMed ID: 32925859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantifying Tertiary Referral Center Bias in Vestibular Schwannoma Research.
    Saba ES; Marinelli JP; Lohse CM; Link MJ; Carlson ML
    Otol Neurotol; 2020 Feb; 41(2):258-264. PubMed ID: 31789811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Conditional Probability of Vestibular Schwannoma Growth at Different Time Points After Initial Stability on an Observational Protocol.
    Sethi M; Borsetto D; Cho Y; Gair J; Gamazo N; Jefferies S; Joannides A; Mannion R; Helmy A; Axon P; Donnelly N; Tysome JR; Bance M
    Otol Neurotol; 2020 Feb; 41(2):250-257. PubMed ID: 31613836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Volumetric growth rates of untreated vestibular schwannomas.
    Schnurman Z; Nakamura A; McQuinn MW; Golfinos JG; Roland JT; Kondziolka D
    J Neurosurg; 2019 Aug; 133(3):742-748. PubMed ID: 31374553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Cross-sectional Survey of the North American Skull Base Society: Current Practice Patterns of Vestibular Schwannoma Evaluation and Management in North America.
    Carlson ML; Van Gompel JJ; Wiet RM; Tombers NM; Devaiah AK; Lal D; Morcos JJ; Link MJ
    J Neurol Surg B Skull Base; 2018 Jun; 79(3):289-296. PubMed ID: 29765827
    [No Abstract]   [Full Text] [Related]  

  • 36. Natural History of Sporadic Vestibular Schwannoma: A Volumetric Study of Tumor Growth.
    Lees KA; Tombers NM; Link MJ; Driscoll CL; Neff BA; Van Gompel JJ; Lane JI; Lohse CM; Carlson ML
    Otolaryngol Head Neck Surg; 2018 Sep; 159(3):535-542. PubMed ID: 29685084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single Institutional Experience With Observing 564 Vestibular Schwannomas: Factors Associated With Tumor Growth.
    Hunter JB; Francis DO; O'Connell BP; Kabagambe EK; Bennett ML; Wanna GB; Rivas A; Thompson RC; Haynes DS
    Otol Neurotol; 2016 Dec; 37(10):1630-1636. PubMed ID: 27668793
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.